Latest News and Press Releases
Want to stay updated on the latest news?
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Vera Therapeutics Appoints Christopher Hite to Board of Directors
-
Vera Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results
-
Vera Therapeutics to Participate at Upcoming Investor Conferences
-
Vera Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4).
-
Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer
-
Vera Therapeutics to participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
-
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
-
Vera Therapeutics announces proposed public offering of Class A common stock.